Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques.
about
Point-of-Care Testing of Hemostasis in Cardiac SurgeryPostoperative treatment with low molecular weight heparin after right heart assist for coronary artery bypass graftingInfluence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgeryManagement of antiplatelet therapy for minimization of bleeding risk before cardiac surgeryA comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery.Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.Coagulopathies in cyanotic cardiac patients: An analysis with three point - of - care testing devices (Thromboelastography, rotational thromboelastometry, and sonoclot analyzer).The effects of platelet inhibitors on blood use in cardiac surgery.A new mixture ratio of heparin for the cell salvage device.Monitoring of heparin and its low-molecular-weight analogs by silicon field effect.Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans.Anesthesia for endovascular neurosurgery.Genetics of coagulation: considerations for cardiac surgery.Antitcoagulant and antiplatelet activities of scolymoside.Warm ischemia provokes inflammation and regional hypercoagulability within the heart during off-pump coronary artery bypass: a possible target for serine protease inhibition.Anticoagulation and coagulation management for ECMO.Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.Electrochemical heparin sensing at liquid/liquid interfaces and polymeric membranes.The coagulopathy of cardiopulmonary bypass.High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass.Use of point-of-care testing for plasma therapy.Heparin sensing and binding - taking supramolecular chemistry towards clinical applications.Acute Kidney Injury in Cardiac Surgery and Cardiac Intensive Care.Comparison of current practices of cardiopulmonary perfusion technology in Iran with American Society of Extracorporeal Technology's standards.Are all heparins safe for on-pump heart surgery?Antiplatelet, anticoagulant, and profibrinolytic activities of baicalin.Factors affecting postoperative blood loss in children undergoing cardiac surgery.Thromboelastography (TEG)-based algorithm reduces blood product utilization in patients undergoing VAD implant.Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor.Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume.Protamine inhibits tissue factor-initiated extrinsic coagulation.Antithrombotic and antiplatelet activities of pelargonidin in vivo and in vitro.Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa.Heparin triggered dose dependent multi-color emission switching in water: a convenient protocol for heparinase I estimation in real-life biological fluids.Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy.Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery.
P2860
Q24806594-6F4D930E-F5D8-4404-B7D5-A60485591213Q28193139-18FBCAD3-8D5D-4405-9A16-AA3723EFDA7EQ28195148-84F20A81-E095-46F2-89AD-8FD0EF069402Q28201103-477E4AC3-9FD7-49A0-BCB9-1AB377ACB5ABQ33396248-5A45FD2A-69B2-496C-A2EB-6E9769803857Q33422490-A0C2CFB5-DD98-497D-A547-600EFBEC654EQ33440826-2E8E7CE2-1BEA-4352-B7E2-0CDA43EBCBA3Q34510678-41B5437B-8496-4DF6-B096-FFE8CE4EEB0CQ34765817-6870BEC4-E26C-41C2-8B6F-62DB6FF96FAAQ35037245-F92ABD99-7E3D-429A-ACD0-C06C0E523C37Q36163207-FFDA0DEF-7DCF-456B-BC45-D277B18AE9D0Q36611360-CF698EDF-6630-426B-AFA4-14C0C2501071Q36629801-7BCF67C8-819C-487F-8DA1-4CC070DC2627Q36697910-3F6FFF58-1923-4967-8828-44C4B6694416Q37013823-493436AD-0EA4-495D-AF9B-FD5A8611658AQ37020944-745DFAE9-C7F2-4231-AA30-814654FED743Q37600544-B7DBF488-635B-43D3-9926-98A6F50EFB1FQ37741178-EE6D0032-8680-44D1-9840-F1E72020E484Q37777962-34E3DBB7-2301-4534-AABE-D2D2A489CE49Q37851496-9D9537FC-8CE4-4271-90B4-852417B95CAAQ37946690-A09CE33E-9650-47F2-8A33-B8F626523D6BQ38009421-37D36410-E95D-46EB-8129-F2817BCBF786Q38135753-7E04C032-7317-412F-AA84-B8E85289CC62Q38667382-5ED09E27-2BC8-46F7-B910-AEEBD4E13A56Q39526287-9D9E4677-6648-4601-AD11-0E0537EE8F3AQ39849280-82477A4E-B0E0-431C-B8E5-E1D7A63BD0E9Q42217401-8ACB9A36-41B0-42B3-8BAF-2ABD14438D7FQ42530895-4482F688-9425-48F3-B7C9-7F84703E4292Q43443972-A42BE25C-3E96-4719-95FB-7D168CFFCA45Q44632467-B6FF9225-478F-4145-9081-75A1E59325D3Q47752943-6F52085B-E121-433D-8939-3F1CC4226FA8Q48715377-DCD8457A-15EC-441C-B689-842E28A2A412Q50270193-880E5C88-1BDE-4C9D-BB49-3ACB357CCAF5Q50447480-5E0D6C2A-41B3-40AF-8C08-181095E026FBQ50954821-03117A90-AE3C-4AC4-AFB8-873D7CB349F0Q51033642-DAD7F48F-983B-4CC3-9656-31A7E265F082Q51314323-108B56F6-5572-42E5-B935-1A62257A6B1D
P2860
Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@ast
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@en
type
label
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@ast
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@en
prefLabel
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@ast
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@en
P2093
P1433
P1476
Anticoagulation monitoring dur ...... rrent and emerging techniques.
@en
P2093
P304
P356
10.1097/00000542-199910000-00031
P407
P577
1999-10-01T00:00:00Z